Novo Nordisk is committed to continuous improvement of our economic performance. Setting high objectives and targets and reporting on progress in meeting those goals are core elements of the Novo Nordisk Way of Management. In this section you will find links to the relevant economic data reported in our Sustainability Report 2003. This section includes both the financial and economic highlights.
The Sustainability Report is assured according to AA1000AS.You can read about the assurance of the Sustainability Report in the section ‘Accounting for our performance’.
An overview of Novo Nordisk’s general key performance data from 2000 to 2003 is available in the section on Key performance data.
Economic footprint
Read about Novo Nordisk economic footprint in the article 'Measuring our economic footprint' . Here you will also be able to view statistics on Cash value distribution .
Affordable insulin
One of the major dilemmas for Novo Nordisk is access to health. Read about how Novo Nordisk is dealing with the dilemma in 'More affordable insulin' and 'Investments in health'. Here you will also be able to view statistics on the economic impact of treatment of diabetes in Denmark and Bangladesh.
